download (3).jpg

Rapid Antibody Tests

FVAD_JPG.webp

SAHPRA APPROVED COVID-19 IgG/IgM Antibody Rapid Test

 

Superior quality colloidal gold, IgG/IgM Rapid Test

PCR testing resources, and its limitations, necessitated looking for alternative testing platforms that could be used. SARS-CoV-2 Point Of Care Antibody testing has been developed as an adjunct to the existing
standard PCR test for diagnosis as well as assisting with the testing of asymptomatic individuals and
epidemiological investigations to describe the extent or prevalence of infection.


These tests may be used to:


✓ determine the rate of exposure or prevalence of infection in specific populations
✓ identify individuals who have been exposed to SARS-CoV-2 as possible donors of
convalescent plasma as a possible treatment option for COVID-19 disease
✓ confirm infection in individuals that have a clinical illness that suggests COVID-19 but
have negative PCR results
✓ assist with workplace and health care worker screening
✓ be used in SARS-CoV-2 vaccine research to determine vaccine efficacy
✓ assess whether an individual still possess antibodies and therefore has built up a certain level of immunity


The IgG/IgM Rapid Test Cassette is a lateral flow chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to 2019-nCoV in human whole blood, serum or plasma specimens.